Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target
Top Cited Papers
Open Access
- 30 June 2015
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 41 (7), 569-576
- https://doi.org/10.1016/j.ctrv.2015.04.004
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- miR-301a as an NF-κB activator in pancreatic cancer cellsThe EMBO Journal, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Toll-like receptors regulate B cell cytokine production in patients with diabetesDiabetologia, 2010
- Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathwayCytokine, 2009
- Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetesDiabetologia, 2009
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- TLR accessory moleculesCurrent Opinion in Immunology, 2008
- Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose TissueObesity, 2008
- Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipidsAtherosclerosis, 2008